TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
JAMCO Pharma Consulting AB
Closing information (x1000 SEK)
Closing information | 2024/09 | 2023/09 | 2022/09 |
Turnover |
6,610
|
6,107 | |
Financial expenses |
0
|
354 | |
Earnings before taxes |
4,589
|
3,782 | |
EBITDA |
4,187
|
1,975 | |
Total assets |
22,237
|
18,211 | |
Current assets |
8,664
|
7,932 | |
Current liabilities |
2,862
|
1,917 | |
Equity capital |
19,045
|
15,366 | |
- share capital |
50
![]() |
50 | |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Solvency |
85.6%
|
84.4% | |
Turnover per employee |
3,305
|
3,054 | |
Profit as a percentage of turnover |
69.4%
|
61.9% | |
Return on assets (ROA) |
20.6%
|
22.7% | |
Current ratio |
302.7%
|
413.8% | |
Return on equity (ROE) |
24.1%
|
24.6% | |
Change turnover |
503
|
1,252 | |
Change turnover % |
-12%
|
8%
|
26% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/09 | 2023/09 | 2022/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.